Pages Menu
Categories Menu

REPRIEVE Site Newsletters

Newsletter 10/09/2017 | PDF

Newsletter 09/25/2017 | PDF

Newsletter 09/11/2017 | PDF

Newsletter 08/22/2017 | PDF

Newsletter 08/07/2017 | PDF

Newsletter 07/26/2017 | PDF

Newsletter 07/10/2017 | PDF

Newsletter 06/26/2017 | PDF

Newsletter 06/12/2017 | PDF

Newsletter 05/22/2017 | PDF

Newsletter 05/08/2017 | PDF

Newsletter 04/24/2017 | PDF

Newsletter 04/10/2017 | PDF

Newsletter 03/27/2017 | PDF

Newsletter 03/13/2017 | PDF

Newsletter 02/27/2017 | PDF

Newsletter 02/13/2017 | PDF

Newsletter 01/23/2017 | PDF

Newsletter 01/9/2017 | PDF

Newsletter 12/12/2016 | PDF

Newsletter 11/14/2016 | PDF

Newsletter 10/24/2016 | PDF

Newsletter 10/10/2016 | PDF

Newsletter 09/26/2016 | PDF

Newsletter 09/12/2016 | PDF

Newsletter 08/22/2016 | PDF

Newsletter 08/08/2016 | PDF

Newsletter 07/25/2016 | PDF

Newsletter 07/11/2016 | PDF

Newsletter 06/27/2016 | PDF

Newsletter 06/13/2016 | PDF

Newsletter 05/23/2016 | PDF

Newsletter 05/09/2016 | PDF

Newsletter 04/25/2016 | PDF

Newsletter 04/11/2016 | PDF

Newsletter 03/28/2016 | PDF

Newsletter 03/14/2016 | PDF

Newsletter 02/22/2016 | PDF

Newsletter 02/08/2016 | PDF

Newsletter 01/25/2016 | PDF

Newsletter 01/12/2016 | PDF

Newsletter 12/14/2015 | PDF

Newsletter 11/23/2015 | PDF

Newsletter 11/09/2015 | PDF

Newsletter 10/26/2015 | PDF

Newsletter 10/12/2015 | PDF

Newsletter 09/28/2015 | PDF

Newsletter 09/14/2015 | PDF

Newsletter 08/24/2015 | PDF

Newsletter 08/10/2015 | PDF

Newsletter 07/27/2015 | PDF

Newsletter 07/13/2015 | PDF

Newsletter 06/22/2015 | PDF

Newsletter 06/08/2015 | PDF

Newsletter 05/25/2015 | PDF

Newsletter 05/11/2015 | PDF

Newsletter 04/27/2015 | PDF

Newsletter 04/13/2015 | PDF

Newsletter 03/23/2015 | PDF

Newsletter 03/09/2015 | PDF

We’re currently seeking study participants to take part in REPRIEVE. Please contact us to learn more.

Contact Us

Latest Tweets

reprievetrial @reprievetrial
REPRIEVE Trial  @reprievetrialThis @pozmagazine article examines the promising future of #HIV treatment, mentioning the REPRIEVE Trial https://t.co/lfYi7vonOA 
REPRIEVE Trial  @reprievetrialToday is #NLAAD: #HIV increases the risk of heart disease. See how #NIH is addressing this problem https://t.co/Cwxiosck1B 
REPRIEVE Trial  @reprievetrialRT @pozmagazine:Living longer with #HIV is a great thing- here's why it's important to know how aging and #HIV intersect https://t.co/uSKsZ1Yj17